ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Debt to Equity Over TimeCompressed
Percentile Rank36
3Y CAGR-30.7%
5Y CAGR-28.5%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-30.7%/yr
Annual compound
5Y CAGR
-28.5%/yr
Consistent
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.14+19.2%
20240.12-76.0%
20230.48+16.2%
20220.41-40.3%
20210.69-6.2%
20200.74+116.1%
2019-4.59-13.4%
2018-4.04+39.2%
2017-6.65-110.2%
201665.54-